Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.

OBJECTIVE To compare survival and local recurrence outcomes in dogs with mast cell tumors with incomplete or close margins treated with primary re-excision or radiation therapy of the primary site versus no additional local therapy. STUDY DESIGN Retrospective case series. ANIMALS Dogs (n = 64). METHODS Outcomes of canine mast cell tumor cases that had incomplete or close surgical resection and presented to the Ontario Veterinary College Health Sciences Centre (2001-2010) were evaluated after additional local therapy (primary re-excision or radiation therapy) or no additional local therapy (comparison). Follow-up was performed through evaluation of medical records and telephone contact with referring veterinarians and owners. RESULTS Tumors (n = 70) in 64 dogs were studied. Median survival times for the primary re-excision (2930 days) and radiation therapy (2194 days) groups were significantly longer than for the comparison (710 days) group. Local recurrence occurred in 13% of the re-excision group, 8% of the radiation therapy group, and 38% of the comparison group. Although local recurrence rate was not statistically significant for the re-excision group, time to local recurrence was statistically longer for both the re-excision and radiation groups. Adjunctive chemotherapy was not associated with improved survival or local control. CONCLUSION/CLINICAL RELEVANCE There is significant improvement in survival and duration of local control when additional local therapy is performed after incomplete or close resection of mast cell tumors. These follow-up therapies should be recommended to owners when mast cell tumors are incompletely or closely resected.

[1]  L. Marconato,et al.  Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision. , 2012, Journal of the American Veterinary Medical Association.

[2]  A. Gruber,et al.  Recommended Guidelines for Submission, Trimming, Margin Evaluation, and Reporting of Tumor Biopsy Specimens in Veterinary Surgical Pathology , 2011, Veterinary pathology.

[3]  J D Webster,et al.  Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological Behavior , 2011, Veterinary pathology.

[4]  J. Kirpensteijn,et al.  Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: a randomized, double-blind, placebo-controlled study. , 2008, Veterinary surgery : VS.

[5]  C. Reilly,et al.  Mitotic Index Is Predictive for Survival for Canine Cutaneous Mast Cell Tumors , 2007, Veterinary pathology.

[6]  B. Powers,et al.  Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004). , 2007, Journal of the American Veterinary Medical Association.

[7]  D. Thamm,et al.  Chapter 19 – Mast Cell Tumors , 2007 .

[8]  G. Citro,et al.  Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors. , 2006, Anticancer research.

[9]  L. Forrest,et al.  Radiation therapy for incompletely excised grade II canine mast cell tumors. , 2006, Journal of the American Animal Hospital Association.

[10]  M. Besancon,et al.  Recurrence Rate, Clinical Outcome, and Cellular Proliferation: Indices as Prognostic Indicators after Incomplete Surgical Excision of Cutaneous Grade II Mast Cell Tumors: 28 Dogs (1994–2002) , 2006 .

[11]  K. Smith,et al.  Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours , 2006, Veterinary Record.

[12]  M. Mayer.  Radiation therapy for canine mast cell tumors. , 2006, The Canadian veterinary journal = La revue veterinaire canadienne.

[13]  D. Thamm,et al.  Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004). , 2006, Journal of the American Veterinary Medical Association.

[14]  P. Bergman,et al.  Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. , 2006, Journal of the American Veterinary Medical Association.

[15]  N. Northrup,et al.  Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors. , 2004, Journal of the American Animal Hospital Association.

[16]  I. Robertson,et al.  Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. , 2004, Journal of the American Animal Hospital Association.

[17]  P. Bergman,et al.  Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. , 2004, Journal of the American Veterinary Medical Association.

[18]  D. Knapp,et al.  Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. , 2002, Journal of the American Animal Hospital Association.

[19]  F. Shofer,et al.  Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. , 2002, Journal of the American Animal Hospital Association.

[20]  G. Ogilvie,et al.  Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). , 2001, Journal of the American Veterinary Medical Association.

[21]  G. Mauldin,et al.  A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. , 1996, Journal of veterinary internal medicine.

[22]  E. Macewen,et al.  Canine Cutaneous Mast Cell Tumor: Morphologic Grading and Survival Time in 83 Dogs , 1984, Veterinary pathology.